2 %Three (2%) patients with malaria co-infection and nine (2%) without malaria were hospitalised.
KenyaCOVID-19 · paludismepublished 2026The Lancet. Global healthPubMeddocument of 8 observations
Gold tier: mechanically validated evidence, with its primary source.
6,677 evidence items · page 11 / 268
2 %Three (2%) patients with malaria co-infection and nine (2%) without malaria were hospitalised.
KenyaCOVID-19 · paludismepublished 2026The Lancet. Global healthPubMeddocument of 8 observations
2.61 aHRAsymptomatic infections were associated with an increased 1 month likelihood of symptomatic malaria with an adjusted hazard ratio of 2.61.
Kenyapaludismepublished 2021eLifePubMeddocument of 4 observations
37.3 %The age group most affected with ductal carcinoma was 20–34 years (37.3%).
Kenyaductal carcinomapublished 2023The Pan African medical journalPubMeddocument of 14 observations
17.9 %The prevalence of STIs was 17.9% among Kenyan women aged ≥18 and ≤30 years enrolled in a trial of doxycycline post-exposure prophylaxis.
KenyaSTIsobserved between February 2020 and November 2021published 2023BMC women's healthPubMeddocument of 11 observations
79 %During SLATE II, 79% of patients with ≥1 tuberculosis (TB) symptom were tested for TB.
Kenyatuberculoseobserved SLATE IIpublished 2020BMJ openPubMeddocument of 12 observations
10 %Fewer than 10% of people with hypertension in sub-Saharan Africa are diagnosed, linked to care, and achieve hypertension control.
Kenyahypertension artériellepublished 2022PloS onePubMeddocument of 7 observations
EBV methylation was significantly lower in the malaria group compared to controls in both plasma and saliva (P < .05), indicating increased EBV lytic replication.
Kenyapaludisme · virus Epstein-Barrpublished 2024The Journal of infectious diseasesPubMeddocument of 3 observations
29 %Among 1313 male partners traced, 29% were in the pre-hypertension stage.
Kenyapre-hypertensionpublished 2023MedicinePubMeddocument of 5 observations
21.5 %Submicroscopic infection prevalence was 21.5% (n = 144) in the lakeshore zone in the 2020 rainy season.
Kenyapaludismeobserved 2020 rainy seasonpublished 2022PloS onePubMeddocument of 15 observations
16.4 %Resistance to rifampicin (RIF) among HIV-negative tuberculosis patients in Western Kenya was 16.4%.
Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations
31.25 %The prevalence rate of high-risk human papillomavirus (hrHPV) infection among female kidney transplant recipients in Kenyatta National Hospital, Nairobi-Kenya was 31.25% (10 out of 32).
Kenyahigh-risk human papillomavirus (hrHPV) infectionpublished 2022African health sciencesPubMeddocument of 9 observations
38 %P. falciparum PCR-positive prevalence was 38% for Olyset® users among 254 children analysed.
Kenyapaludismepublished 2020Malaria journalPubMeddocument of 6 observations
1 yearCross-subtype neutralizing antibody breadth was detected within a year of superinfection in two individuals.
KenyaVIH/sidapublished 2012PLoS pathogenseurope_pmcdocument of 3 observationsDOI 10.1371/journal.ppat.1002611
2,198 individualsData from 2198 Kenyan children diagnosed with severe malaria were used in the study.
Kenyapaludismepublished 2022Nature communicationsPubMeddocument of 2 observations
28.5 %Resistance to isoniazid (INH) among HIV-negative tuberculosis patients in Western Kenya was 28.5%.
Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations
30.3 %Among 396 participants in an HIV incidence cohort in Kenya, 120 (30.3%) had never heard of pre-exposure prophylaxis (PrEP).
KenyaVIH/sidapublished 2024Journal of the International AIDS SocietyPubMeddocument of 6 observations
0.05 relative_risk_ratioSwitching to second-line antiretroviral therapy was associated with lower mortality, with a relative risk ratio less than 0.05 (95% confidence interval: less than 0.05 to 0.1).
KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations
Interwave intervals for SARS-CoV-2 infection in coastal Kenya increased from ≤3 months in 2021 to ≥6 months in 2024.
KenyaCOVID-19observed 2021, 2024published 2026Open forum infectious diseaseseurope_pmcdocument of 4 observations
0.12 odds_ratioThose with parasitemia 1–100 p/μL had lower odds of accurate diagnosis (OR = 0.12; 95% CI: 0.05–0.29).
Kenyapaludismepublished 2026Malaria journalPubMeddocument of 10 observations
47.9 %Among older adults living with HIV with hypertension in western Kenya, 47.9% achieved blood pressure control.
Kenyahypertension artériellepublished 2026BMC cardiovascular disordersPubMeddocument of 6 observations
14.1 %Anopheles rivulorum had a Plasmodium falciparum sporozoite rate of 14.1% (9/64).
Kenyapaludismepublished 2022Scientific reportsPubMeddocument of 8 observations
97 %Recent HIV self-testing use was 97% among peer clients as reported by clients.
KenyaVIH/sidapublished 2024Frontiers in public healthPubMeddocument of 7 observations
AFRICOS participants had significantly lower rates of obesity compared to DC Cohort participants.
Kenyaobésitépublished 2022PloS onePubMeddocument of 13 observations
14 %14% of cancer outpatients were underweight, with 25.5% of males and 9.4% of females being underweight.
Kenyacancer (non précisé)published 2018Double Burden of Malnutrition among Cancer Outpatients in Nairobi, Kenya: Challenges and OOpenAlexdocument of 8 observations
18 %The mean difference in Plasmodium falciparum parasite prevalence between rural and urban settlements in East Africa was 18%.
Kenyapaludismepublished 2005Acta tropicaeurope_pmcdocument of 3 observationsDOI 10.1016/j.actatropica.2004.08.010
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.